Rubric Capital Management LP
Q1 2023 13F-HR Holdings
Net value change ($000)
+1,563,061
(68.1%)
New positions
11
Sold out positions
35
Turnover %
34.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| STNG | 135,401 | NEW |
| CCJ | 117,093 | 2065.9% |
| VST | 59,056 | NEW |
| FCNCA | 51,631 | NEW |
| CSTM | 45,696 | NEW |
| TEVA | 39,823 | NEW |
| CTI BIOPHARMA CORP | 37,646 | NEW |
| BGC | 35,029 | 50.9% |
| OFIX | 34,232 | NEW |
| RNW | 33,357 | 266.1% |
Top Reduces (Value $000, Stocks/ETFs)
| NFE | -71,363 | -100.0% |
| WSC | -56,079 | -100.0% |
| NE | -48,549 | -83.8% |
| VAL | -41,121 | -100.0% |
| DENBURY INC | -34,269 | -100.0% |
| AHCO | -31,273 | -43.2% |
| Amryt Pharma plc | -26,280 | -100.0% |
| BHC | -25,452 | -100.0% |
| QNST | -19,526 | -100.0% |
| EVER | -18,375 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,346,920
(34.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|